LAUREN IARROBINO: Open Payments
NPI 1710362728 · AMITYVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 30 payments from 11 companies in 2025. Trend: 2023 $268 · 2024 $646 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $348 |
| Novo Nordisk Inc | 9 | $146 |
| Exact Sciences Corporation | 2 | $60 |
| PFIZER INC. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $43 |
| Corcept Therapeutics | 2 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
Products named: AIRSUPRA, Wegovy, Cologuard Collection Kit, Kerendia, PREVNAR 20, Korlym, Veozah, Rybelsus.
Industry payments across NY — which companies pay providers there.
